Inovio Pharma (INO) Weaker as Feuerstein Says CEO Prepping Investors for Study Failure
Tweet Send to a Friend
Inovio Pharma (NYSE: INO) is seeing mid-day weakness following reports from TheStreet's Adam Feuerstein that the company's CEO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
